Batavia Bioservices is a biopharmaceutical process development services Company dedicated to add value to customers by providing high quality biopharmaceuticals for proof-of -concept and pre-clinical product development studies. The company focuses on the early stages of product development with services ranging for DNA cloning and mammalian cell line generation, to upstream process development, purification and product characterization. Headquartered in Leiden, The Netherlands, Batavia Bioservices is privileged to have strong strategic partners in both the Netherlands and the United States of America. Batavia Bioservices is a limited liability company that is not publicly traded.